Vericel Corp. (VCEL)
40.15
+0.71
(+1.80%)
USD |
NASDAQ |
Oct 02, 16:00
40.15
0.00 (0.00%)
After-Hours: 20:00
Vericel Price : 40.15 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 40.01 | 40.40 | 39.37 | 40.15 | 479214.0 |
| Oct 01, 2026 | 40.27 | 40.72 | 39.29 | 39.44 | 497333.0 |
| Sep 30, 2026 | 40.79 | 41.08 | 39.82 | 40.14 | 585379.0 |
| Sep 29, 2026 | 40.27 | 40.82 | 39.93 | 40.61 | 526887.0 |
| Sep 28, 2026 | 39.78 | 41.05 | 39.65 | 40.24 | 643091.0 |
| Sep 25, 2026 | 39.30 | 39.80 | 38.74 | 39.71 | 359896.0 |
| Sep 24, 2026 | 38.86 | 39.40 | 38.38 | 39.30 | 351977.0 |
| Sep 23, 2026 | 39.95 | 40.10 | 38.21 | 38.79 | 433961.0 |
| Sep 22, 2026 | 40.00 | 40.42 | 39.55 | 40.22 | 546957.0 |
| Sep 21, 2026 | 40.08 | 40.29 | 39.05 | 39.55 | 402176.0 |
| Sep 18, 2026 | 39.80 | 40.21 | 39.56 | 40.02 | 1.126M |
| Sep 17, 2026 | 40.62 | 40.62 | 39.06 | 40.03 | 536421.0 |
| Sep 16, 2026 | 39.73 | 40.87 | 39.72 | 40.21 | 490484.0 |
| Sep 15, 2026 | 39.39 | 40.14 | 38.54 | 39.72 | 654832.0 |
| Sep 14, 2026 | 38.58 | 39.70 | 38.20 | 39.60 | 629429.0 |
| Sep 11, 2026 | 38.39 | 38.94 | 37.35 | 38.34 | 503531.0 |
| Sep 10, 2026 | 38.56 | 38.82 | 37.67 | 37.87 | 340237.0 |
| Sep 09, 2026 | 38.72 | 39.19 | 38.53 | 38.99 | 366515.0 |
| Sep 08, 2026 | 39.69 | 39.72 | 38.74 | 39.08 | 410295.0 |
| Sep 04, 2026 | 40.04 | 40.57 | 39.85 | 40.19 | 312915.0 |
| Sep 03, 2026 | 41.30 | 41.30 | 40.08 | 40.47 | 301274.0 |
| Sep 02, 2026 | 40.49 | 41.49 | 40.35 | 40.89 | 395530.0 |
| Sep 01, 2026 | 39.87 | 41.44 | 39.66 | 40.50 | 651114.0 |
| Aug 31, 2026 | 40.48 | 40.88 | 39.34 | 39.90 | 636305.0 |
| Aug 28, 2026 | 41.18 | 41.46 | 40.51 | 40.95 | 491248.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 262.82 |
| ADMA Biologics, Inc. | 9.72 |
| Kyntra Bio, Inc. | 6.31 |
| Conexeu Sciences, Inc. | 3.10 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
Price Related Metrics
| PE Ratio | 86.85 |
| PS Ratio | 6.786 |
| PEG Ratio | 0.3204 |
| Price to Book Value | 5.552 |
| Price to Free Cash Flow | 33.71 |
| Earnings Yield | 1.15% |
| Market Cap | 2.055B |
| PEGY Ratio | 0.3204 |
| Operating PE Ratio | 113.98 |
| Normalized PE Ratio | 86.87 |